{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:48:14Z","timestamp":1770403694380,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2017,3,15]]},"DOI":"10.5664\/jcsm.6478","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T15:39:17Z","timestamp":1489505957000},"page":"363-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is it Time for Immunotherapy Trials in Narcolepsy?"],"prefix":"10.1007","volume":"13","author":[{"given":"Andreas","family":"Lutterotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"issue":"3","key":"1303002_CR1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","volume":"68","author":"E Mignot","year":"2001","unstructured":"Mignot E, Lin L, Rogers W et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2001;68(3):686\u2013699.","journal-title":"Am J Hum Genet"},{"key":"1303002_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","volume":"50","author":"SS Ahmed","year":"2014","unstructured":"Ahmed SS, Schur PH, MacDonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmunity. 2014;50:1\u201311.","journal-title":"J Autoimmunity"},{"issue":"3","key":"1303002_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.20603","volume":"58","author":"W Chen","year":"2005","unstructured":"Chen W, Black J, Call P, Mignot E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann Neurol. 2005;58(3):489\u2013490.","journal-title":"Ann Neurol"},{"issue":"1","key":"1303002_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.20892","volume":"60","author":"Y Dauvilliers","year":"2006","unstructured":"Dauvilliers Y. Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol. 2006;60(1):153.","journal-title":"Ann Neurol"},{"issue":"6","key":"1303002_CR5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","volume":"56","author":"Y Dauvilliers","year":"2004","unstructured":"Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004;56(6):905\u2013908.","journal-title":"Ann Neurol"},{"issue":"1","key":"1303002_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31825dce03","volume":"79","author":"S Knudsen","year":"2012","unstructured":"Knudsen S, Biering-S\u00f8rensen B, Kornum BR et al. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency. Neurology. 2012;79(1):102\u2013103.","journal-title":"Neurology"},{"issue":"4","key":"1303002_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","volume":"12","author":"M Lecendreux","year":"2003","unstructured":"Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res. 2003;12(4):347\u2013348.","journal-title":"J Sleep Res"},{"issue":"10","key":"1303002_CR8","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00415-008-0983-7","volume":"255","author":"G Plazzi","year":"2008","unstructured":"Plazzi G, Poli F, Franceschini C et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol. 2008;255(10):1549\u20131554.","journal-title":"J Neurol"},{"issue":"12","key":"1303002_CR9","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00415-008-0996-2","volume":"255","author":"PO Valko","year":"2008","unstructured":"Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol. 2008;255(12):1900\u20131903.","journal-title":"J Neurol"},{"issue":"3","key":"1303002_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5664\/jcsm.6500","volume":"13","author":"M Lecendreux","year":"2017","unstructured":"Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C. Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study. J Clin Sleep Med. 2017;13(3):441\u2013453.","journal-title":"J Clin Sleep Med"},{"issue":"294","key":"1303002_CR11","doi-asserted-by":"crossref","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","volume":"7","author":"SS Ahmed","year":"2015","unstructured":"Ahmed SS, Volkmuth W, Duca J et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med. 2015;7(294):294ra105.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1303002_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","volume":"120","author":"V Cvetkovic-Lopes","year":"2010","unstructured":"Cvetkovic-Lopes V, Bayer L, Dorsaz S et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest. 2010;120(3):713\u2013719.","journal-title":"J Clin Invest"},{"issue":"7","key":"1303002_CR13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","volume":"33","author":"M Kawashima","year":"2010","unstructured":"Kawashima M, Lin L, Tanaka S et al. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep. 2010;33(7):869\u2013874.","journal-title":"Sleep"},{"issue":"7","key":"1303002_CR14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","volume":"33","author":"H Toyoda","year":"2010","unstructured":"Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep. 2010;33(7):875\u2013878.","journal-title":"Sleep"},{"issue":"10","key":"1303002_CR15","first-page":"1305","volume":"70","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Bauer J, Rigau V et al. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 2013;70(10):1305\u20131310.","journal-title":"JAMA Neurol"},{"key":"1303002_CR16","unstructured":"Ramberger M, H\u00f6gl B, Stefani A, Mitterling T, Reindl M, Lutterotti A CD4+ T cell reactivity to orexin\/hypocretin in patients with narcolepsy type 1. Sleep. in press."}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.6478\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.aasmnet.org\/jcsm\/ViewAbstract.aspx?pid=30958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:17:06Z","timestamp":1770365826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.6478"}},"subtitle":["Commentary on Lecendreux et al. Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study. J Clin Sleep Med. 2017;13(3):441\u2013453"],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3,15]]}},"alternative-id":["1303002"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.6478","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}